An endovascular stent for placement at a vascular injury site for inhibiting restenosis at the site is provided, the stent comprising a structural member or body formed of one or more filaments and carried on the stent-body filament(s), a drug-release coating composed of (i) 20-70 weight percent polymer substrate and (ii) 30-80 weight percent of a macrocyclic triene immunosuppressive compound, wherein the coating substrate comprises a polylactic acid polymer.
